Filter results
You can narrow down the results using the filters
Content type
Topic
Disease
Search results
-
Invasive Group A Streptococcal (iGAS) Disease – CDNA National guidelines for Public Health Units
2 January 2024 - These guidelines outline Australia’s national minimum standard for surveillance, laboratory testing, case management and contact management for Invasive Group A Streptococcal (iGAS) disease.
-
Murray Valley encephalitis virus infection – Surveillance case definition
1 January 2024 - This document contains the surveillance case definition for Murray Valley encephalitis virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.
-
West Nile/Kunjin virus infection – Surveillance case definition
1 January 2024 - This document contains the surveillance case definition for West Nile/Kunjin virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.
-
HIV Taskforce report
22 December 2023 - This report provides advice to the Australian Government on HIV prevention, testing, treatment, awareness raising, decriminalisation, destigmatisation and partnership.
-
enHealth literature review – Vapour intrusions: hazardous ground gases
20 December 2023 - The report aims to guide health assessment and management of sites impacted by vapor intrusion in Australia.
-
enHealth guidance – The human health risk assessment of volatile chlorinated hydrocarbon vapour intrusion
20 December 2023 - This document summarizes health risks related to vapor intrusion. It aligns with Agency for Toxic Substances and Disease Registry (ATSDR) guidelines for assessing the public health impact of vapour intrusion.
-
Diphtheria – Surveillance case definition
12 December 2023 - This document contains the surveillance case definition for diphtheria, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.
-
Gonococcal infection – Laboratory case definition
11 December 2023 - The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for gonococcal infection.
-
National Health and Climate Strategy
3 December 2023 - The National Health and Climate Strategy sets out a whole-of-government plan to address the health and wellbeing impacts of climate change and address the contribution of the health system to climate change.
-
National Health and Climate Strategy – Final thematic stakeholder engagement report
3 December 2023 - This report analyses responses to the consultation paper from 2 June 2023 to 24 July 2023. These responses informed the development of the National Health and Climate Strategy.
-
Invasive Group A Streptococcal disease (iGAS) – Laboratory case definition
22 November 2023 - The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for iGAS disease.
-
Statement of Intent – 10 November 2023
10 November 2023 - This statement outlines how we will work together with state and territory governments to support the establishment and operation of the interim Australian CDC. It includes a timeline for delivering an agreement to support the fully developed Australian CDC.
-
Role and functions of an Australian Centre for Disease Control
10 November 2023 - This discussion paper outlines the draft mission and purpose statements for the Centre for Disease Control (CDC). It includes an outline of its potential scope of functions, examples of how it could improve public health in Australia, and principles guiding its design.
-
Biotoxins (indoor damp and mould) Clinical Pathway
1 November 2023 - The document supports decision-making for general practitioners and other medical professionals for the diagnosis, treatment, and management of patients presenting with biotoxin-related illnesses.
-
HIV Taskforce communique – 20 October 2023
20 October 2023 - This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 20 October 2023.
-
Syphilis (congenital) – Surveillance case definition
30 August 2023 - This document contains the surveillance case definition for syphilis (congenital), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.
-
PHLN referral pathway for poliovirus confirmatory testing
1 August 2023 - This document explains how to collect and transport specimens, and the referral pathway to confirm poliovirus detected in wastewater.
-
HIV Taskforce communique – 11 August 2023
11 July 2023 - This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 11 August 2023.
-
Respiratory syncytial virus – Surveillance case definition
1 July 2023 - This document contains the surveillance case definition for respiratory syncytial virus, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.
-
HIV Taskforce communique – 29 June 2023
29 June 2023 - This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 29 June 2023.
-
Joint national Japanese encephalitis virus outbreak response plan
16 June 2023 - This plan is the first Australian Response Plan for Japanese encephalitis. It provides a framework for nationally co-operative response arrangements for managing Japanese encephalitis virus.
-
HIV Taskforce communique – 3 May 2023
3 May 2023 - This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 3 May 2023.
-
NORDR – Patient privacy and consent statement
29 March 2023 - This document contains the National Occupational Respiratory Disease Registry (NORDR) patient privacy and consent statement.
-
NORDR – Agent personal information collection notice
29 March 2023 - This document contains and consent form and a collection notice that sets out how we will handle the personal information of an agent that is acting on behalf of a physician to access the National Occupational Respiratory Disease Registry (NORDR).
-
NORDR – Physician personal information collection notice
29 March 2023 - This collection notice sets out how we will handle a physician's personal information under the National Occupational Respiratory Disease Registry (NORDR).